Trial intelligence / Profile preview

Digital Medicine Program for Opioid Pain Control in Cancer

NCT04194528Terminated

Sponsor
SWOG Cancer Research Network
Start
Jan 2020
Primary completion
Sep 2020
Countries
1
01

Overview

Open-label, single-arm trial, sponsored by SWOG Cancer Research Network. Primary endpoint: Feasibility Determined by Accrual, Adherence and Patient Retention at 6 months. Started Jan 2020; status: terminated.

Beyond the preview

Go deeper on NCT04194528.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04194528.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call